Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-POU domain-containing octamer-binding protein (NONO, also known as p54nrb) is a multifunctional nuclear protein and member of the Drosophila behaviour/human splicing (DBHS) family. It binds both DNA and RNA, mediating diverse nuclear functions including pre-mRNA splicing, transcriptional regulation, DNA unwinding, and participation in nonhomologous end joining (NHEJ) for DNA repair. NONO forms functional dimers, commonly with SFPQ or PSPC1, and contributes to the assembly of paraspeckles—nuclear substructures involved in the retention of defective RNAs. Aberrant expression of NONO is implicated in a range of human diseases, especially in oncogenesis where it promotes tumor growth, metastasis, and impacts key signaling pathways such as Akt/MAPK and β-catenin. While NONO is investigated as a cancer biomarker and potential therapeutic target, the lack of selective drugs and its critical roles in normal cell biology present substantial safety and specificity challenges for therapeutic modulation.
Experimental silencing (e.g., CRISPR/Cas9) of NONO leads to inhibition of tumorigenic properties in cancer cells, including cell growth, migration, invasion, and stemness (by modulating Akt/MAPK/β-catenin pathways); no currently approved small-molecule or biologic modulators
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-POU domain-containing octamer-binding protein (NONO (also commonly known as p54nrb)).